The Use of 5-Aminolevulinic Acid in Low-Grade Glioma Resection: A Systematic Review
Ahmad Kareem Almekkawi(Brigham and Women's Hospital), Bernard R. Bendok(Brigham and Women's Hospital), Salah G. Aoun(Neurological Surgery), Tarek Y. El Ahmadieh(Neurological Surgery), Najib E. El Tecle(Brigham and Women's Hospital), Aaron Plitt(Neurological Surgery), Eva M. Wu(Brigham and Women's Hospital), Walter Stummer(University of Münster), Toral Patel(VA North Texas Health Care System), Abdullah M. Abunimer(Brigham and Women's Hospital), Karl R. Abi-Aad(Brigham and Women's Hospital)
Cited by 22
Related Papers
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
|The Lancet|2020|1.8k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k